Lactobacillus crispatus modulates epithelial cell defense against Candida albicans through Toll-like receptors 2 and 4, interleukin 8 and human β-defensins 2 and 3

Immunology Letters

Volumn 156, Issue 1-2, 2013, Pages 102-109

  Rizzo, Antonietta ^a   Losacco, Antonio ^a   Carratelli, Caterina Romano ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Candida albicans; Defensins; Lactobacillus crispatus; Toll like receptors

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; INTERLEUKIN 8; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; BETA DEFENSIN; BETA DEFENSIN 3, HUMAN; BETA-DEFENSIN 3, HUMAN; DEFB4A PROTEIN, HUMAN; DEFENSIN; TOLL LIKE RECEPTOR;

ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CELL ADHESION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIUM CELL; FEMALE; FUNGAL VIRULENCE; FUNGUS GROWTH; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; LACTOBACILLUS CRISPATUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; BACTERIUM ADHERENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; HELA CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; LACTOBACILLUS; METABOLISM; MICROBIOLOGY; ORGANISMAL INTERACTION; PHYSIOLOGY; WESTERN BLOTTING; ANTIGEN EXPRESSION; BACTERIAL COLONIZATION; BACTERIAL GROWTH; CELLULAR IMMUNITY; COCULTURE; CYTOKINE PRODUCTION; HELA CELL; PROTEIN BLOOD LEVEL; UROGENITAL SYSTEM; YEAST;

CANDIDA ALBICANS; DEFENSINS; LACTOBACILLUS CRISPATUS; TOLL-LIKE RECEPTORS;

BACTERIAL ADHESION; BETA-DEFENSINS; BLOTTING, WESTERN; CANDIDA ALBICANS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERLEUKIN-8; LACTOBACILLUS; MICROBIAL INTERACTIONS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS;

EID: 84886536182     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2013.08.013     Document Type: Article

References (52)

1. Harriott M.M., Noverr M.C. Importance of Candida-bacterial polymicrobial biofilms in disease. Trends Microbiol 2011, 19:557-563.
2. Semlali A., Leung K.P., Curt S., Rouabhia M. Antimicrobial decapeptide KSL-W attenuates Candida albicans virulence by modulating its effects on Toll-like receptor, human β-defensin, and cytokine expression by engineered human oral mucosa. Peptides 2011, 32:859-867.
3. Crump J.A., Collignon P.J. Intravascular catheter-associated infections. Eur J Clin Microbiol Infect Dis 2000, 19:1-8. [Review].
4. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin Microbiol Rev 2004, 17:255-267.
5. Gudiña E.J., Teixeira J.A., Rodrigues L.R. Isolation and functional characterization of a biosurfactant produced by Lactobacillus paracasei. Colloids Surf B Biointerfaces 2010, 76:298-304.
6. Dongari-Bagtzoglou A. Pathogenesis of mucosal biofilms infections: challenges and progress. Expert Rev Anti Infect Ther 2008, 6:141-144.
7. Bromuro C., Torosantucci A., Gomez M.J., Urbani F., Cassone A. Differential release of an immunodominant 65kDa mannoprotein antigen from yeast and mycelial forms of Candida albicans. J Med Vet Mycol 1994, 32:447-459.
8. Rouabhia M., Ross G., Pagé N., Chakir J. Interleukin-18 and gamma interferon production by oral epithelial cells in response to exposure to Candida albicans or lipopolysaccharide stimulation. Infect Immun 2002, 70:7073-7080.
9. Saunus J.M., Kazoullis A., Farah C.S. Cellular and molecular mechanisms of resistance to oral Candida albicans infections. Front Biosci 2008, 13:5345-5358.
10. Chassot F., Camacho D.P., Patussi E.V., Donatti L., Svidzinski T.I., Consolaro M.E. Can Lactobacillus acidophilus influence the adhesion capacity of Candida albicans on the combined contraceptive vaginal ring?. Contraception 2010, 81:331-335.
11. Oddsson K., Leifels-Fischer B., de Melo N.R., Wiel-Masson D., Benedetto C., Verhoeven C.H., et al. Efficacy and safety of a contraceptive vaginal ring (NuvaRing) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception 2005, 71:176-182.
12. Falagas M.E., Betsi G.I., Athanasiou S. Probiotics for prevention of recurrent vulvovaginal candidiasis: a review. J Antimicrob Chemother 2006, 58:266-272.
13. Rizzo A., Domenico M.D., Carratelli C.R., Paolillo R. The role of Chlamydia and Chlamydophila infections in reactive arthritis. Intern Med 2012, 51:113-117.
14. Rönnqvist P.D., Forsgren-Brusk U.B., Grahn-Håkansson E.E. Lactobacilli in the female genital tract in relation to other genital microbes and vaginal Ph. Acta Obstet Gynecol Scand 2006, 85:726-735.
15. Aroutcheva A., Gariti D., Simon M., Shott S., Faro J., Simoes J.A., et al. Defense factors of vaginal lactobacilli. Am J Obstet Gynecol 2001, 185:375-379.
16. Boris S., Suárez J.E., Vázquez F., Barbés C. Adherence of human vaginal lactobacilli to vaginal epithelial cells and interaction with uropathogens. Infect Immun 1998, 66:1985-1989.
17. Strus M., Kukla G., Rurańska-Smutnicka D., Przondo-Mordarska A., Heczko P. Surface properties of Lactobacillus strains. II. Adherence to tissue culture surfaces. Med Dosw Mikrobiol 2001, 53:253-258.
18. Strus M., Kucharska A., Kukla G., Brzychczy-Włoch M., Maresz K., Heczko P.B. The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida. Infect Dis Obstet Gynecol 2005, 13:69-75.
19. Bahri R., Saidane-Mosbahi D., Rouabhia M. Candida famata modulates toll-like receptor, beta-defensin, and proinflammatory cytokine expression by normal human epithelial cells. J Cell Physiol 2010, 222:209-218.
20. Joly S., Organ C.C., Johnson G.K., McCray P.B., Guthmillerm J.M. Correlation between beta-defensin expression and induction profiles in gingival keratinocytes. Mol Immunol 2005, 42:1073-1084.
21. Feng Z., Jiang B., Chandra J., Ghannoum M., Nelson S., Weinberg A. Human beta-defensins: differential activity against candidal species and regulation by Candida albicans. J Dent Res 2005, 84:445-450.
22. Décanis N., Savignac K., Rouabhia M. Farnesol promotes epithelial cell defense against Candida albicans through Toll-like receptor 2 expression, interleukin-6 and human beta-defensin 2 production. Cytokine 2009, 45:132-140.
23. Mostefaoui Y., Caveau I., Ross G., Rouabhia M. Tissue structure, and IL-1beta IL-8, and TNF-alpha secretions after contact by engineered human oral mucosa with dentifrices. J Clin Periodontol 2002, 29:1035-1041.
24. Mostefaoui Y., Bart C., Frenette M., Rouabhia M. Candida albicans and Streptococcus salivarius modulate IL-6, IL-8, and TNF-alpha expression and secretion by engineered human oral mucosa cells. Cell Microbiol 2004, 6:1085-1096.
25. Takeda K., Akira S. TLR signaling pathways. Semin Immunol 2004, 16:3-9.
26. Liew F.Y., Xu D., Brint E.K., O'Neill L.A. Negative regulation of toll-like receptor-mediated immune responses. Nat Rev Immunol 2005, 5:446-458.
27. Jouault T., Ibata-Ombetta S., Takeuchi O., Trinel P.A., Sacchetti P., Lefebvre P., et al. Candida albicans phospholipomannan is sensed through toll-like receptors. J Infect Dis 2003, 188:165-172.
28. Levitz S.M. Interactions of Toll-like receptors with fungi. Microbes Infect 2004, 6:1351-1355.
29. Pivarcsi A., Bodai L., Réthi B., Kenderessy-Szabó A., Koreck A., Széll M., et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 2003, 15:721-730.
30. Antonio M.A., Rabe L.K., Hillier S.L. Colonization of the rectum by Lactobacillus species and decreased risk of bacterial vaginosis. J Infect Dis 2005, 192:394-398.
31. Marco M.L., Kleerebezem M. Assessment of real-time RT-PCR for quantification of Lactobacillus plantarum gene expression during stationary phase and nutrient starvation. J Appl Microbiol 2008, 104:587-594.
32. Bhatia S.J., Kochar N., Abraham P., Nair N.G., Mehta A.P. Lactobacillus acidophilus inhibits growth of Campylobacter pylori in vitro. J Clin Microbiol 1989, 27:2328-2330.
33. Tallon R., Arias S., Bressollier P., Urdaci M.C. Strain- and matrix-dependent adhesion of Lactobacillus plantarum is mediated by proteinaceous bacterial compounds. J Appl Microbiol 2007, 102:442-451.
34. Martín R., Sánchez B., Suárez J.E., Urdaci M.C. Characterization of the adherence properties of human Lactobacilli strains to be used as vaginal probiotics. FEMS Microbiol Lett 2012, 328:166-173.
35. Romano Carratelli C., Mazzola N., Paolillo R., Sorrentino S., Rizzo A. Toll-like receptor-4 (TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells. FEMS Immunol Med Microbiol 2009, 57:116-124.
36. Paolillo R., Romano Carratelli C., Sorrentino S., Mazzola N., Rizzo A. Immunomodulatory effects of Lactobacillus plantarum on human colon cancer cells. Int Immunopharmacol 2009, 9:1265-1271.
37. Farhat K., Sauter K.S., Brcic M., Frey J., Ulmer A.J., Jungi T.W. The response of HEK293 cells transfected with bovine TLR2 to established pathogen-associated molecular patterns and to bacteria causing mastitis in cattle. Vet Immunol Immunopathol 2008, 125:326-336.
38. Coudeyras S., Jugie G., Vermerie M., Forestier C. Adhesion of human probiotic Lactobacillus rhamnosus to cervical and vaginal cells and interaction with vaginosis-associated pathogens. Infect Dis Obstet Gynecol 2008, 2008:1-5.
39. Crane-Godreau M.A., Wira C.R. Effect of Escherichia coli and Lactobacillus rhamnosus on macrophage inflammatory protein 3 alpha, tumor necrosis factor alpha, and transforming growth factor beta release by polarized rat uterine epithelial cells in culture. Infect Immun 2004, 72:1866-1873.
40. Bahri R., Curt S., Saidane-Mosbahi D., Rouabhia M. Normal human gingival epithelial cells sense C. parapsilosis by toll-like receptors and module its pathogenesis through antimicrobial peptides and proinflammatory cytokines. Mediators Inflamm 2010, 2010:1-13.
41. Shi J., Zeng X., Zhou M., Chen Q. Activation of ERK-FAK signaling pathway and enhancement of cell migration involved in the early interaction between oral keratinocytes and Candida albicans. Mycopathologia 2009, 167:1-7.
42. Rhee S.H., Hwang D. Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NF kappa B and expression of the inducible cyclooxygenase. J Biol Chem 2000, 275:34035-34040.
43. Mambula S.S., Sau K., Henneke P., Golenbock D.T., Levitz S.M. Toll-like receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002, 277:39320-39326.
44. Yauch L.E., Mansour M.K., Shoham S., Rottman J.B., Levitz S.M. Involvement of CD14, toll-like receptors 2 and 4, and MyD88 in the host response to the fungal pathogen Cryptococcus neoformans in vivo. Infect Immun 2004, 72:5373-5382.
45. Villamón E., Gozalbo D., Roig P., O'Connor J.E., Fradelizi D., Gil M.L. Toll-like receptor-2 is essential in murine defenses against Candida albicans infections. Microbes Infect 2004, 6:1-7.
46. Netea M.G., Van Der Graaf C.A., Vonk A.G., Verschueren I., Van Der Meer J.W., Kullberg B.J. The role of toll-like receptor (TLR) 2 and TLR4 in the host defense against disseminated candidiasis. J Infect Dis 2002, 185:1483-1489.
47. Steele C., Fidel P.L. Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 2002, 70:577-583.
48. Nomanbhoy F., Steele C., Yano J., Fidel P.L. Vaginal and oral epithelial cell anti-Candida activity. Infect Immun 2002, 70:7081-7088.
49. Dongari-Bagtzoglou A., Kashleva H. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog 2003, 34:169-177.
50. Plantinga T.S., van Bergenhenegouwen J., Jacobs C., Joosten L.A., van't Land B., Garssen J., et al. Modulation of Toll-like receptor ligands and Candida albicans-induced cytokine responses by specific probiotics. Cytokine 2012, 59:159-165.
51. Burd R.S., Furrer J.L., Sullivan J., Smith A.L. Murine beta-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock 2002, 18:461-464.
52. Ogawa M., Shimizu K., Nomoto K., Tanaka R., Hamabata T., Yamasaki S., et al. Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int J Food Microbiol 2001, 68:135-140.